Scott Kellen

Scott Kellen joined the company in January 2018 as the Vice President of Finance and was appointed as the Chief Financial Officer and Secretary in April 2018.

Before joining DiaMedica, Mr. Kellen served as Vice President and Chief Financial Officer of Sun BioPharma, Inc., a publicly-traded clinical-stage drug development company, from October 2015 until April 2018. From February 2010 to September 2015, Mr. Kellen served as Chief Financial Officer and Secretary of Kips Bay Medical, Inc., a publicly-traded medical device company.